Novo Nordisk stock slides as broker cuts rating ahead of Feb. 4 earnings
Copenhagen, Feb 2, 2026, 10:58 CET — Regular session Novo Nordisk shares dipped Monday following a broker downgrade just before this week’s earnings, adding to the Danish drugmaker’s stock pressure in early February trading. Timing is key. Novo is set to release full-year results on Wednesday, with investors eager to see if demand and pricing for its obesity and diabetes…